pfizer glp 1 drug moves forward with weight-loss GLP-1 pill—a needle-free alternative to Wegovy and Ozempic Pfizer GLP-1 weight loss drug

Description

The remarkable weight loss and glucose-lowering results achieved by the dual peptides paved the way for triple GIP/GLP-1/glucagon receptor triagonists with the hope that the new combinatorial approaches provide further synergistic metabolic effects

Consumers have no way to verify what they're actually getting, what dose they're taking, or what contaminants might be present

Short-acting agents demonstrate strong effects on gastric emptying and are associated with strong postprandial glucose effects

This medication family is known as GLP-1 agonists, and in addition to Ozempic, include Saxenda, Wegovy (which is also semaglutide) and Mounjaro which are already being prescribed off label

In fact, the omitted study was a pooled analysis of 5 RCTs 196,197,198,199,200 of 5,325 patients with obesity followed for up to 3 years, which had shown that liraglutide was no different from placebo for depressive symptoms as scored on the Patient Health Questionnaire-9, while also highlighting a small increased risk of suicidal behavior 193